IMS Health Incorporated (IMS) is a provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers market intelligence products and services, including portfolio optimization capabilities; commercial effectiveness innovations; managed care and consumer health offerings, and consulting and services solutions. The Company’s information products are developed to meet the clients' needs by using data secured from a worldwide network of suppliers in more than 100 countries. During the year ended December 31, 2008, the Company acquired Robinson and James Research Pty Limited, Fourth Hurdle Consulting Limited, Health Benchmarks, Inc., RMBC Pharma Limited, and Skura Corporation, Inc.
Quick Financial Synopsis
BRIEF: For the nine months ended 30 September 2009, IMS Health,Inc.'s revenues decreased 9% to $1.59B. Net income decreased 12% to $186.9M. Revenues reflect a decrease in income from information & analytics and lower revenue from consulting & services. Net income also reflects an lower interest income, higher depreciation & other amortization the presence of severance, impairment & other charges and presence of loss on investment vs. a gain.
Company Address
IMS Health Inc
901 Main Avenue Norwalk CT 06851
P: +1203.8455200